scholarly article | Q13442814 |
P50 | author | Bernhard Luscher | Q41729308 |
Jean-Marc Fritschy | Q56978414 | ||
P2093 | author name string | Fritschy JM | |
Benke D | |||
Mohler H | |||
Laurent JP | |||
Belzung C | |||
Crestani F | |||
Baer K | |||
Essrich C | |||
Lorez M | |||
P2860 | cites work | Benzodiazepine-insensitive mice generated by targeted disruption of the gamma 2 subunit gene of gamma-aminobutyric acid type A receptors | Q28367959 |
Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning | Q29616330 | ||
The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes | Q34481002 | ||
Ethoexperimental approaches to the biology of emotion | Q39466488 | ||
GABAA receptor channels | Q40389943 | ||
Emotion: systems, cells, synaptic plasticity | Q41000800 | ||
Cognitive dysfunction resulting from hippocampal hyperactivity--a possible cause of anxiety disorder? | Q41454704 | ||
Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein | Q43522858 | ||
Contribution of human hippocampal region to novelty detection. | Q45976705 | ||
Hippocampectomy impairs the memory of recently, but not remotely, acquired trace eyeblink conditioned responses | Q46100838 | ||
Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study | Q47675005 | ||
Decreased benzodiazepine receptor binding in panic disorder measured by IOMAZENIL-SPECT. A preliminary report | Q48224486 | ||
Postsynaptic clustering of major GABAA receptor subtypes requires the gamma 2 subunit and gephyrin | Q48240102 | ||
Relationships between trait and state anxiety and the central benzodiazepine receptor: a PET study | Q48248166 | ||
Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: a fractal analysis | Q48585862 | ||
A focal brain abnormality in panic disorder, a severe form of anxiety | Q48633253 | ||
Link between emotional memory and anxiety states: A study by principal component analysis | Q48802566 | ||
The behavioral salience of tones as indicated by prepulse inhibition of the startle response: relationship to hearing loss and central neural plasticity in C57BL/6J mice | Q48916579 | ||
PKC gamma mutant mice exhibit mild deficits in spatial and contextual learning. | Q51138420 | ||
Differential effect of benzodiazepine sedation in high and low anxious patients in a "real life" stress setting. | Q51217659 | ||
Effects of ibotenic lesions of mammillary bodies on spontaneous and rewarded spatial alternation in mice. | Q52108635 | ||
Hippocampal long-term potentiation and neural cell adhesion molecules L1 and NCAM | Q59098946 | ||
Behavioural Validation of a Light/Dark Choice Procedure for Testing Anti-Anxiety Agents | Q63951857 | ||
Reduced benzodiazepine receptor binding in panic disorders measured by iomazenil SPECT | Q71368033 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | anxiety | Q154430 |
bias | Q742736 | ||
P304 | page(s) | 833-839 | |
P577 | publication date | 1999-09-01 | |
P1433 | published in | Nature Neuroscience | Q1535359 |
P1476 | title | Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues | |
P478 | volume | 2 |
Q28297569 | 50 years of hurdles and hope in anxiolytic drug discovery |
Q30538580 | A balanced chromosomal translocation disrupting ARHGEF9 is associated with epilepsy, anxiety, aggression, and mental retardation |
Q39444689 | A deficit of brain dystrophin impairs specific amygdala GABAergic transmission and enhances defensive behaviour in mice |
Q51439231 | A gene promotes anxiety in mice-and also in scientists. |
Q51886373 | A genetically defined morphologically and functionally unique subset of 5-HT neurons in the mouse raphe nuclei. |
Q34464870 | A novel GABRG2 mutation, p.R136*, in a family with GEFS+ and extended phenotypes. |
Q64084403 | Ablation of glucocorticoid receptor in the hindbrain of the mouse provides a novel model to investigate stress disorders |
Q44678361 | Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background |
Q48243676 | Absence of anxiolytic response to chlordiazepoxide in two common background strains exposed to the elevated plus-maze: importance and implications of behavioural baseline |
Q28588180 | Absence of dopamine D4 receptors results in enhanced reactivity to unconditioned, but not conditioned, fear |
Q42641765 | Activin tunes GABAergic neurotransmission and modulates anxiety-like behavior. |
Q48718504 | Adult hippocampal neurogenesis is involved in anxiety-related behaviors |
Q36411530 | Alcohol, GABA receptors, and neurodevelopmental disorders |
Q43563922 | Alterations in dystrophin and utrophin expression parallel the reorganization of GABAergic synapses in a mouse model of temporal lobe epilepsy. |
Q34976116 | Altered GABA transmission in a mouse model of increased trait anxiety |
Q42263969 | Altered GABAA receptor expression in brainstem nuclei and SUDEP in Gabrg2(+/Q390X) mice associated with epileptic encephalopathy |
Q57173780 | An Emerging Circuit Pharmacology of GABA Receptors |
Q42377342 | An Essential Role for the Tetraspanin LHFPL4 in the Cell-Type-Specific Targeting and Clustering of Synaptic GABAA Receptors. |
Q30538152 | An anxiety-like phenotype in mice selectively bred for aggression |
Q42683643 | An asymmetric contribution to gamma-aminobutyric type A receptor function of a conserved lysine within TM2-3 of alpha1, beta2, and gamma2 subunits |
Q36025710 | Angiotensin II AT1 receptor blocker candesartan prevents the fast up-regulation of cerebrocortical benzodiazepine-1 receptors induced by acute inflammatory and restraint stress |
Q47915510 | Anti-anhedonic effect of selective serotonin reuptake inhibitors with affinity for sigma-1 receptors in picrotoxin-treated mice. |
Q35924378 | Anxiety and depression: mouse genetics and pharmacological approaches to the role of GABA(A) receptor subtypes |
Q30502573 | Anxiety from a phylogenetic perspective: is there a qualitative difference between human and animal anxiety? |
Q51074707 | Anxiety in healthy humans is associated with orbital frontal chemistry. |
Q48128422 | Anxiety: at the intersection of genes and experience. |
Q47980674 | Anxiolytic-like effects of α-asarone in a mouse model of chronic pain |
Q37440206 | Association study between GABA receptor genes and anxiety spectrum disorders |
Q48304837 | Association study of GABRG2 polymorphisms with suicidal behaviour in schizophrenia patients with alcohol use disorder |
Q36562979 | Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice. |
Q42644507 | Behavioral profile of wild mice in the elevated plus-maze test for anxiety |
Q35187183 | Behavioral profiles of inbred strains on novel olfactory, spatial and emotional tests for reference memory in mice |
Q42634214 | Behavioural analysis of four mouse strains in an anxiety test battery |
Q45079493 | Behavioural correlates of an altered balance between synaptic and extrasynaptic GABAAergic inhibition in a mouse model. |
Q30451624 | Benzodiazepine-induced anxiolysis and reduction of conditioned fear are mediated by distinct GABAA receptor subtypes in mice |
Q30466591 | Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes |
Q41729281 | Bidirectional Homeostatic Regulation of a Depression-Related Brain State by Gamma-Aminobutyric Acidergic Deficits and Ketamine Treatment |
Q36994585 | Borna disease virus P protein affects neural transmission through interactions with gamma-aminobutyric acid receptor-associated protein |
Q38183555 | Borna disease virus infection in cats. |
Q91641482 | Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience |
Q39990495 | Calcium-modulating cyclophilin ligand regulates membrane trafficking of postsynaptic GABA(A) receptors. |
Q35115978 | Central GABAergic systems and depressive illness |
Q43919465 | Changes in GABAA receptor gamma 2 subunit gene expression induced by long-term administration of oral contraceptives in rats |
Q49109928 | Chemical mapping of anxiety in the brain of healthy humans: an in vivo 1H-MRS study on the effects of sex, age, and brain region |
Q34435101 | Combining genetic and genomic approaches to study mood disorders |
Q27305122 | Complex control of GABA(A) receptor subunit mRNA expression: variation, covariation, and genetic regulation |
Q35690731 | Concussive brain injury enhances fear learning and excitatory processes in the amygdala |
Q48615603 | Contrasting phenotypes of C57BL/6JOlaHsd, 129S2/SvHsd and 129/SvEv mice in two exploration-based tests of anxiety-related behaviour |
Q47349501 | Correcting miR92a-vGAT-Mediated GABAergic Dysfunctions Rescues Human Tau-Induced Anxiety in Mice |
Q64102147 | Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions |
Q26750907 | Cortical and subcortical gamma amino acid butyric acid deficits in anxiety and stress disorders: Clinical implications |
Q48156052 | Cortical thinning in obsessive compulsive disorder. |
Q44835112 | Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. |
Q30490998 | Critical role of the 65-kDa isoform of glutamic acid decarboxylase in consolidation and generalization of Pavlovian fear memory |
Q27637525 | Crystal structure of the GABAA-receptor-associated protein, GABARAP |
Q34249227 | Current perspectives on the pathophysiology of schizophrenia, depression, and anxiety disorders |
Q34798306 | Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase Cepsilon. |
Q48129765 | Defects at the crossroads of GABAergic signaling in generalized genetic epilepsies |
Q34615783 | Defects in dendrite and spine maturation and synaptogenesis associated with an anxious-depressive-like phenotype of GABAA receptor-deficient mice |
Q43536237 | Deficiency of the 65 kDa isoform of glutamic acid decarboxylase impairs extinction of cued but not contextual fear memory. |
Q30532216 | Deficits in trace cued fear conditioning in galanin-treated rats and galanin-overexpressing transgenic mice |
Q35881844 | Diabetes induces GABA receptor plasticity in murine vagal motor neurons |
Q35546401 | Diagnostic Criteria for Psychiatric Disorders for Use with Adults with Learning Disabilities/Mental Retardation(DC‐LD) and the diagnosis of anxiety disorders: a review |
Q64084725 | Diazepam Accelerates GABAR Synaptic Exchange and Alters Intracellular Trafficking |
Q34136074 | Differences between trait fear and trait anxiety: Implications for psychopathology |
Q43233240 | Differential localization of gamma-aminobutyric acid type A and glycine receptor subunits and gephyrin in the human pons, medulla oblongata and uppermost cervical segment of the spinal cord: an immunohistochemical study. |
Q39732193 | Differential molecular and behavioural alterations in mouse models of GABRG2 haploinsufficiency versus dominant negative mutations associated with human epilepsy |
Q43648884 | Differential sensitivity to the anxiolytic effects of ethanol and flunitrazepam in PKCgamma null mutant mice |
Q104509542 | Disinhibition of somatostatin interneurons confers resilience to stress in male but not female mice |
Q36509663 | Distinct gamma2 subunit domains mediate clustering and synaptic function of postsynaptic GABAA receptors and gephyrin. |
Q44971605 | Does amygdaloid corticotropin-releasing hormone (CRH) mediate anxiety-like behaviors? Dissociation of anxiogenic effects and CRH release |
Q37136743 | Dopamine D4 Receptors Regulate GABAA Receptor Trafficking via an Actin/Cofilin/Myosin-dependent Mechanism. |
Q34749269 | Drug interactions at GABA(A) receptors |
Q47744146 | Early growth response 1 (Egr-1) directly regulates GABAA receptor α2, α4, and θ subunits in the hippocampus |
Q35115792 | Early life experience shapes the functional organization of stress-responsive visceral circuits |
Q33895482 | Early-life infection is a vulnerability factor for aging-related glial alterations and cognitive decline |
Q37703475 | Effects of Traumatic Stress Induced in the Juvenile Period on the Expression of Gamma-Aminobutyric Acid Receptor Type A Subunits in Adult Rat Brain |
Q46936239 | Effects of baclofen on anxiety, sexual motivation, and olfactory perception in male mice in different psychoemotional states |
Q34097713 | Embryonic GABA(B) receptor blockade alters cell migration, adult hypothalamic structure, and anxiety- and depression-like behaviors sex specifically in mice |
Q42145810 | Emotion and cognition in high and low stress sensitive mouse strains: a combined neuroendocrine and behavioral study in BALB/c and C57BL/6J mice. |
Q46894690 | Enhanced behavioral sensitivity to the competitive GABA agonist, gaboxadol, in transgenic mice over-expressing hippocampal extrasynaptic alpha6beta GABA(A) receptors |
Q48560999 | Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor. |
Q35236855 | Experimental animal models for the simulation of depression and anxiety. |
Q42436062 | Facilitated CA1 hippocampal synaptic plasticity in dystrophin-deficient mice: role for GABAA receptors? |
Q45183577 | Fluoxetine disrupts the integration of anxiety and aversive memories |
Q38427758 | Functional neuroanatomy on the working memory under emotional distraction in patients with generalized anxiety disorder |
Q95804738 | GABA GABA A: modulating sensitivity to drugs and alcohol |
Q46914797 | GABA concentrations in the human anterior cingulate cortex predict negative BOLD responses in fMRI. |
Q30363617 | GABA receptor subunit distribution and FMRP-mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autism. |
Q34204921 | GABA(A) receptor subtypes: dissecting their pharmacological functions |
Q43540494 | GABA(A) receptors containing (alpha)5 subunits in the CA1 and CA3 hippocampal fields regulate ethanol-motivated behaviors: an extended ethanol reward circuitry. |
Q43968692 | GABA-ergic modulation of prefrontal spatio-temporal activation pattern during emotional processing: a combined fMRI/MEG study with placebo and lorazepam. |
Q64986634 | GABAA Receptor Density Is Not Altered by a Novel Herbal Anxiolytic Treatment. |
Q34569409 | GABAA receptor drugs and neuronal plasticity in reward and aversion: focus on the ventral tegmental area |
Q24801914 | GABAA receptor gamma 2 subunit knockdown mice have enhanced anxiety-like behavior but unaltered hypnotic response to benzodiazepines. |
Q30421260 | GABAA receptor subtypes: Therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism |
Q34979365 | GABAA receptor trafficking-mediated plasticity of inhibitory synapses |
Q41984180 | GABAA receptor α and γ subunits shape synaptic currents via different mechanisms |
Q28241963 | GABAA receptor-acting neurosteroids: a role in the development and regulation of the stress response |
Q36637673 | GABAA receptors as targets for novel anxiolytic drugs |
Q36659853 | GABAA receptors in central nervous system disease: anxiety, epilepsy, and insomnia |
Q34400464 | GABAA-receptor plasticity during long-term exposure to and withdrawal from progesterone |
Q38947394 | GABAergic Regulation of Adult Hippocampal Neurogenesis |
Q36740355 | GABAergic control of adult hippocampal neurogenesis in relation to behavior indicative of trait anxiety and depression states |
Q34448259 | GABAergic control of critical developmental periods for anxiety- and depression-related behavior in mice |
Q36668325 | GABAergic control of depression-related brain states |
Q28478892 | GABAergic gene expression in postmortem hippocampus from alcoholics and cocaine addicts; corresponding findings in alcohol-naïve P and NP rats |
Q42531323 | GIT1 and βPIX are essential for GABA(A) receptor synaptic stability and inhibitory neurotransmission. |
Q48416202 | Galanin peptide levels in hippocampus and cortex of galanin-overexpressing transgenic mice evaluated for cognitive performance |
Q34271352 | Gender-specific contribution of the GABAA subunit genes on 5q33 in methamphetamine use disorder |
Q48179004 | Generalisation of conditioned fear and its behavioural expression in mice. |
Q35746041 | Generalised Anxiety Disorder--A Twin Study of Genetic Architecture, Genome-Wide Association and Differential Gene Expression |
Q36021405 | Genetic Deletion of the Clathrin Adaptor GGA3 Reduces Anxiety and Alters GABAergic Transmission |
Q35104041 | Genetic animal models of anxiety |
Q34517497 | Genetic basis of anxiety-like behaviour: a critical review |
Q36064163 | Genetic biomarkers of depression |
Q44281916 | Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. |
Q30478587 | Genetics of anxiety and trauma-related disorders |
Q46798855 | Gephyrin regulates the cell surface dynamics of synaptic GABAA receptors. |
Q30486159 | Glutamatergic and GABAergic modulations of ultrasonic vocalizations during maternal separation distress in mouse pups |
Q24613178 | Glyoxalase 1 increases anxiety by reducing GABAA receptor agonist methylglyoxal |
Q40056976 | Heat induced temperature dysregulation and seizures in Dravet Syndrome/GEFS+ Gabrg2+/Q390X mice |
Q42498243 | Heterogeneity of hippocampal GABA(A) receptors: regulation by corticosterone. |
Q47157251 | Hippocampal GABA enables inhibitory control over unwanted thoughts. |
Q35214789 | Hippocampal modulation of sensorimotor processes |
Q37872468 | Hippocampal regulation of aversive memories. |
Q27437613 | Human stiff-person syndrome IgG induces anxious behavior in rats |
Q34573086 | Imidazenil and diazepam increase locomotor activity in mice exposed to protracted social isolation. |
Q33931028 | Impaired GABA(A) receptor endocytosis and its correlation to spatial memory deficits |
Q36013388 | Impaired GABAergic transmission and altered hippocampal synaptic plasticity in collybistin-deficient mice |
Q34085629 | Increase in expression of the GABA(A) receptor alpha(4) subunit gene induced by withdrawal of, but not by long-term treatment with, benzodiazepine full or partial agonists |
Q41586786 | Increased Motor-Impairing Effects of the Neuroactive Steroid Pregnanolone in Mice with Targeted Inactivation of the GABAA Receptor γ2 Subunit in the Cerebellum. |
Q28586201 | Increased anxiety-like behavior and enhanced synaptic efficacy in the amygdala of GluR5 knockout mice |
Q30492433 | Induction of neuronal vascular endothelial growth factor expression by cAMP in the dentate gyrus of the hippocampus is required for antidepressant-like behaviors |
Q29616854 | Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve |
Q100723177 | Inhibition of GABA interneurons in the mPFC is sufficient and necessary for rapid antidepressant responses |
Q31900249 | Input-dependent synaptic targeting of alpha(2)-subunit-containing GABA(A) receptors in synapses of hippocampal pyramidal cells of the rat. |
Q41281812 | Investigation of ethanol-induced impairment of spatial memory in gamma2 heterozygous knockout mice. |
Q46796503 | Investigation of the abundance and subunit composition of GABAA receptor subtypes in the cerebellum of alpha1-subunit-deficient mice. |
Q46684358 | Juvenile stress-induced alteration of maturation of the GABAA receptor alpha subunit in the rat. |
Q47965028 | Learning and memory performance in mice lacking the GAL-R1 subtype of galanin receptor |
Q48690295 | Localisation and stress-induced plasticity of GABAA receptor subunits within the cellular networks of the mouse dorsal raphe nucleus |
Q31966789 | Localization of two major GABA(A) receptor subunits in the dentate gyrus of the rat and cell type-specific up-regulation following entorhinal cortex lesion. |
Q43205095 | Lorazepam modulates orbitofrontal signal changes during emotional processing in catatonia |
Q43594220 | Loss of the major GABA(A) receptor subtype in the brain is not lethal in mice. |
Q34789999 | Making sense of nonsense GABA(A) receptor mutations associated with genetic epilepsies |
Q34420641 | Measuring normal and pathological anxiety-like behaviour in mice: a review. |
Q34995058 | Mechanisms of GABAA receptor assembly and trafficking: implications for the modulation of inhibitory neurotransmission. |
Q37856287 | Medicinal chemistry of ρ GABAC receptors. |
Q36624181 | Meditation and Yoga can Modulate Brain Mechanisms that affect Behavior and Anxiety-A Modern Scientific Perspective |
Q28510086 | Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses |
Q38883198 | Molecular Pathogenic Basis for GABRG2 Mutations Associated With a Spectrum of Epilepsy Syndromes, From Generalized Absence Epilepsy to Dravet Syndrome |
Q92010373 | Molecular basis for and chemogenetic modulation of comorbidities in GABRG2-deficient epilepsies |
Q33194775 | Molecular dissection of the amygdala and its relevance to autism |
Q34510367 | Molecular pathways of anxiety revealed by knockout mice |
Q37127405 | Molecular targets of anxiety: from membrane to nucleus. |
Q34574021 | Mouse anxiety: the power of knockout |
Q36841480 | Multiple molecular mechanisms for a single GABAA mutation in epilepsy |
Q33717685 | Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors |
Q39311440 | Neurobiological mechanisms of stress resilience and implications for the aged population. |
Q51071588 | Neurobiology of anxiety and fear: challenges for genomic science of the new millennium. |
Q32064653 | Neurobiology of generalized anxiety disorder |
Q30498893 | Neurobiology of memory and anxiety: from genes to behavior |
Q35971833 | Neurosteroids and GABA-A Receptor Function |
Q52641631 | Neurosteroids in Schizophrenia: Pathogenic and Therapeutic Implications. |
Q36666746 | Neurosteroids, stress and depression: potential therapeutic opportunities. |
Q46704914 | Neurotensin enhances GABAergic activity in rat hippocampus CA1 region by modulating L-type calcium channels |
Q30493888 | On the importance of inhibition: central and peripheral manifestations of nonlinear inhibitory processes in neural systems |
Q48726910 | Orexins, sleep and arousal |
Q47108015 | Overexpression of transmembrane protein 168 in the mouse nucleus accumbens induces anxiety and sensorimotor gating deficit |
Q33506763 | Parallel changes in gene expression in peripheral blood mononuclear cells and the brain after maternal separation in the mouse |
Q38579331 | Pathophysiological aspects of diversity in neuronal inhibition: a new benzodiazepine pharmacology |
Q41159670 | Pathway analysis of genome-wide association datasets of personality traits |
Q48272441 | Phospholipase C-related inactive protein is involved in trafficking of gamma2 subunit-containing GABA(A) receptors to the cell surface. |
Q43757605 | Post-training excitotoxic lesions of the dorsal hippocampus attenuate forward trace, backward trace, and delay fear conditioning in a temporally specific manner |
Q46935379 | Presynaptic terminals independently regulate synaptic clustering and autophagy of GABAA receptors in Caenorhabditis elegans. |
Q47316274 | Prodepressant- and anxiogenic-like effects of serotonin-selective, but not noradrenaline-selective, antidepressant agents in mice lacking α2-containing GABAA receptors |
Q48173710 | Prodynorphin gene deletion increased anxiety-like behaviours, impaired the anxiolytic effect of bromazepam and altered GABAA receptor subunits gene expression in the amygdala |
Q33919784 | Progesterone withdrawal increases the alpha4 subunit of the GABA(A) receptor in male rats in association with anxiety and altered pharmacology - a comparison with female rats. |
Q45743608 | Progressive postnatal assembly of limbic-autonomic circuits revealed by central transneuronal transport of pseudorabies virus. |
Q47820916 | Protein kinase C is essential for kainate-induced anxiety-related behavior and glutamatergic synapse upregulation in prelimbic cortex. |
Q36692356 | Psychological risk factors in headache |
Q35806141 | Quantitative localisation of synaptic and extrasynaptic GABAA receptor subunits on hippocampal pyramidal cells by freeze-fracture replica immunolabelling. |
Q33927727 | Reduced GABAergic inhibition in the basolateral amygdala and the development of anxiety-like behaviors after mild traumatic brain injury. |
Q30486124 | Reduced conditioned fear response in mice that lack Dlx1 and show subtype-specific loss of interneurons |
Q43757430 | Region-specific developmental specialization of GABA-glycine cosynapses in laminas I-II of the rat spinal dorsal horn. |
Q36866354 | Regulation of anxiety during the postpartum period |
Q27649952 | Regulation of synaptic inhibition by phospho-dependent binding of the AP2 complex to a YECL motif in the GABAA receptor 2 subunit |
Q30474166 | Removal of GABA(A) receptor γ2 subunits from parvalbumin neurons causes wide-ranging behavioral alterations |
Q39182365 | Reward memory relieves anxiety-related behavior through synaptic strengthening and protein kinase C in dentate gyrus |
Q34583254 | Role of GABA in anxiety and depression |
Q36407601 | Role of Glyoxalase 1 (Glo1) and methylglyoxal (MG) in behavior: recent advances and mechanistic insights |
Q77354257 | Role of allopregnanolone in regulation of GABA(A) receptor plasticity during long-term exposure to and withdrawal from progesterone |
Q48651137 | Role of bombesin (BN)-like peptides/receptors in emotional behavior by comparison of three strains of BN-like peptide receptor knockout mice |
Q28579679 | Sex differences in anxiety, sensorimotor gating and expression of the alpha4 subunit of the GABAA receptor in the amygdala after progesterone withdrawal |
Q33954793 | Sex differences in diazepam effects and parvalbumin-positive GABA neurons in trait anxiety Long Evans rats |
Q48032618 | Short- and long-term effects of juvenile stressor exposure on the expression of GABAA receptor subunits in rats |
Q52540485 | Single-channel properties of neuronal GABAA receptors from mice lacking the 2 subunit. |
Q42375144 | Slow degradation and aggregation in vitro of mutant GABAA receptor gamma2(Q351X) subunits associated with epilepsy |
Q34634067 | Stop that! Inhibition, sensitization, and their neurovisceral concomitants |
Q34400471 | Stress and neuroactive steroids |
Q34349185 | Subcellular localization and regulation of GABAA receptors and associated proteins |
Q33720433 | Suppression of conditioning to ambiguous cues by pharmacogenetic inhibition of the dentate gyrus |
Q40237197 | Synaptic GABAA receptors are directly recruited from their extrasynaptic counterparts |
Q51076448 | Synaptic plasticity in the basolateral amygdala in transgenic mice expressing dominant-negative cAMP response element-binding protein (CREB) in forebrain. |
Q44734604 | TNF-α downregulates inhibitory neurotransmission through protein phosphatase 1-dependent trafficking of GABA(A) receptors |
Q46437590 | Targeted invalidation of CCK2 receptor gene induces anxiolytic-like action in light-dark exploration, but not in fear conditioning test |
Q30464954 | The GABAergic deficit hypothesis of major depressive disorder. |
Q40395726 | The GABRG2 mutation, Q351X, associated with generalized epilepsy with febrile seizures plus, has both loss of function and dominant-negative suppression |
Q39593426 | The GABRG2 nonsense mutation, Q40X, associated with Dravet syndrome activated NMD and generated a truncated subunit that was partially rescued by aminoglycoside-induced stop codon read-through. |
Q38282318 | The GAD65 knock out mouse - a model for GABAergic processes in fear- and stress-induced psychopathology |
Q30462832 | The age of anxiety: role of animal models of anxiolytic action in drug discovery |
Q36247092 | The ascent of mouse: advances in modelling human depression and anxiety |
Q30473428 | The biology of fear- and anxiety-related behaviors |
Q30474232 | The clinical implications of mouse models of enhanced anxiety. |
Q28586332 | The dosage of the neuroD2 transcription factor regulates amygdala development and emotional learning |
Q35244210 | The dynamic modulation of GABA(A) receptor trafficking and its role in regulating the plasticity of inhibitory synapses |
Q24672913 | The gamma-aminobutyric acid type A (GABAA) receptor-associated protein (GABARAP) promotes GABAA receptor clustering and modulates the channel kinetics |
Q27312345 | The human epilepsy mutation GABRG2(Q390X) causes chronic subunit accumulation and neurodegeneration |
Q35977083 | The intronic GABRG2 mutation, IVS6+2T->G, associated with childhood absence epilepsy altered subunit mRNA intron splicing, activated nonsense-mediated decay, and produced a stable truncated γ2 subunit |
Q35202929 | The neurobiology and control of anxious states |
Q36712354 | The relevance of neuroactive steroids in schizophrenia, depression, and anxiety disorders |
Q24630566 | The role of the GABRA2 polymorphism in multiplex alcohol dependence families with minimal comorbidity: within-family association and linkage analyses |
Q34438172 | The social brain: transcriptome assembly and characterization of the hippocampus from a social subterranean rodent, the colonial tuco-tuco (Ctenomys sociabilis) |
Q36613901 | Tiagabine in anxiety disorders |
Q35087068 | Toward a molecular architecture of personality. |
Q84967046 | Toward an efficient and integrative analysis of limited-choice behavioral experiments |
Q34133337 | Trace fear conditioning in mice. |
Q28594296 | Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors |
Q30500598 | Trace fear conditioning is enhanced in mice lacking the delta subunit of the GABAA receptor |
Q39145945 | Trafficking-deficient mutant GABRG2 subunit amount may modify epilepsy phenotype |
Q41856355 | Type A GABA-receptor-dependent synaptic transmission sculpts dendritic arbor structure in Xenopus tadpoles in vivo. |
Q37389012 | Ubiquitin-dependent lysosomal targeting of GABA(A) receptors regulates neuronal inhibition |
Q44978629 | Variability in the benzodiazepine response of serotonin 5-HT1A receptor null mice displaying anxiety-like phenotype: evidence for genetic modifiers in the 5-HT-mediated regulation of GABA(A) receptors. |
Q30496339 | gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression |
Q34295813 | α2-containing GABA(A) receptors: a target for the development of novel treatment strategies for CNS disorders. |
Q47853123 | α4βδ-GABAA receptors in dorsal hippocampal CA1 of adolescent female rats traffic to the plasma membrane of dendritic spines following voluntary exercise and contribute to protection of animals from activity-based anorexia through localization at exc |
Q58712240 | γ2 GABAR Trafficking and the Consequences of Human Genetic Variation |
Search more.